Ethan K. Brodsky1,2, Walter F. Block2,3,
William Schelman4,5, Scott B. Reeder1,2
1Radiology, University of Wisconsin,
Madison, WI, United States; 2Medical Physics, University of
Wisconsin, Madison, WI, United States; 3Biomedical Engineering,
University of Wisconsin, Madison, WI, United States; 4Carbone
Cancer Center, University of Wisconsin, Madison, WI, United States; 5Medicine,
University of Wisconsin, Madison, WI, United States
Detection,
characterization, and monitoring of hepatocellular carcinoma (HCC) is
challenging due to its variable and rapid arterial enhancement. The ability
to monitor changes in both morphology and perfusion is essential for
evaluating the effectiveness of anti-angiogenic therapies. Multiple-phase
CE-MRI has traditionally been used, but suffers from limited temporal
resolution and an inability to consistently match acquisitions to the desired
enhancement phase. We demonstrate the feasibility of contrast-enhanced
isotropic-resolution 3DPR acquisition at 3T using a 32-channel coil with
real-time monitoring that allows breath-holds to be matched to the desired
enhancement phase and enables retrospective selection of the temporal window
showing optimal lesion contrast.